FDA Clears Ustekinumab (Stelara) for Crohn ' s Disease FDA Clears Ustekinumab (Stelara) for Crohn ' s Disease

In clinical trials, most patients who responded to induction therapy with ustekinumab and continued treatment achieved remission of symptoms.FDA Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology News Alert Source Type: news